Annual Operating Expenses
$14.74 M
-$10.72 M-42.11%
December 1, 2024
Summary
- As of March 10, 2025, CMMB annual total operating expenses is $14.74 million, with the most recent change of -$10.72 million (-42.11%) on December 1, 2024.
- During the last 3 years, CMMB annual operating expenses has risen by +$2.37 million (+19.18%).
- CMMB annual operating expenses is now -48.34% below its all-time high of $28.53 million, reached on December 31, 2022.
Performance
CMMB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$3.21 M
-$497.00 K-13.40%
December 1, 2024
Summary
- As of March 10, 2025, CMMB quarterly total operating expenses is $3.21 million, with the most recent change of -$497.00 thousand (-13.40%) on December 1, 2024.
- Over the past year, CMMB quarterly operating expenses has stayed the same.
- CMMB quarterly operating expenses is now -64.49% below its all-time high of $9.05 million, reached on March 31, 2023.
Performance
CMMB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CMMB Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -42.1% | 0.0% |
3 y3 years | +19.2% | 0.0% |
5 y5 years | +146.8% | 0.0% |
CMMB Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -48.3% | +19.2% | -64.5% | at low |
5 y | 5-year | -48.3% | +146.8% | -64.5% | +191.8% |
alltime | all time | -48.3% | +146.8% | -64.5% | +191.8% |
Chemomab Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $14.74 M(-42.1%) | $3.21 M(-13.4%) |
Sep 2024 | - | $3.71 M(-1.5%) |
Jun 2024 | - | $3.77 M(-6.9%) |
Mar 2024 | - | $4.05 M(+5.2%) |
Dec 2023 | $25.46 M(-10.8%) | $3.85 M(-11.9%) |
Sep 2023 | - | $4.37 M(-46.7%) |
Jun 2023 | - | $8.20 M(-9.4%) |
Mar 2023 | - | $9.05 M(+4.7%) |
Dec 2022 | $28.53 M | $8.64 M(+3.9%) |
Sep 2022 | - | $8.32 M(+33.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $6.25 M(+17.6%) |
Mar 2022 | - | $5.32 M(+5.9%) |
Dec 2021 | $12.37 M(+107.1%) | $5.02 M(+73.8%) |
Sep 2021 | - | $2.89 M(+5.0%) |
Jun 2021 | - | $2.75 M(+62.0%) |
Mar 2021 | - | $1.70 M(-12.5%) |
Dec 2020 | $5.97 M | $1.94 M(+58.5%) |
Sep 2020 | - | $1.23 M(+11.3%) |
Jun 2020 | - | $1.10 M(-35.4%) |
Mar 2020 | - | $1.70 M |
FAQ
- What is Chemomab Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual operating expenses year-on-year change?
- What is Chemomab Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly operating expenses year-on-year change?
What is Chemomab Therapeutics annual total operating expenses?
The current annual operating expenses of CMMB is $14.74 M
What is the all time high annual operating expenses for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual total operating expenses is $28.53 M
What is Chemomab Therapeutics annual operating expenses year-on-year change?
Over the past year, CMMB annual total operating expenses has changed by -$10.72 M (-42.11%)
What is Chemomab Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CMMB is $3.21 M
What is the all time high quarterly operating expenses for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly total operating expenses is $9.05 M
What is Chemomab Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CMMB quarterly total operating expenses has changed by $0.00 (0.00%)